Chronic Kidney Disease Among Hypertensive Patients: Need for Screening Programmes
Silvana
Nader Nagib (1), Saeed Abdelwahab (2), Ghada Essam El Din Amin (3) and Mohamed
Farouk Allam (1)*
1.
Department of Family Medicine, Faculty of Medicine, Ain Shams University.
2.
Department of Internal Medicine and Nephrology, Faculty of Medicine, Ain Shams
University.
3.
Department of Community, Environmental and Occupational Medicine, Faculty of
Medicine, Ain Shams University.
American
Jounral of Biomedical Science & Research 2021 - 11(4). AJBSR.MS.ID.001656.
DOI:
10.34297/AJBSR.2021.11.001656
Abstract
Chronic
kidney disease (CKD) has a high morbidity and mortality rates and costs a lot
of money including health care, haemodialysis costs and management of
complications of CKD. Patients with more progressive stages 3 and 4 CKD
experience a high incidence of cardiovascular events and death compared with
stages 1 and 2 of CKD. According to the Global Burden of Disease Study conducted
in 2010, CKD became the 18th place on a list of the greatest causes of deaths
in the world, with an annual mortality rate of 16.3 per 100,000 people. Due to
the high prevalence of diabetes, hypertension and coronary artery disease, CKD
became world widespread. In alignment with the presence of metabolic and
cardiovascular diseases, the prevalence of hypertensive nephropathy prevalence
is 7.75%. Unfortunately, the number of patients started to develop end stage
renal disease because of hypertension is exceeding. Hypertension-induced renal
damage includes the systemic blood pressure load, the degree of renal
microvasculature affection, and local susceptibility factors to barotrauma, all
of which are affected by the degrees of hypertension. Therefore, in developing
countries, screening programmes are extremely needed to detect the early stages
of CKD among hypertensive diabetics and non-diabetic patients attending primary
healthcare centres.
Keywords: Screening, Health Programmes, Chronic Kidney Disease, Hypertension,
Primary healthcare centres.
American
Jounral of Biomedical Science & Research 2021 - 11(4). AJBSR.MS.ID.001656.
